Lecturer, Department of Population Health, University of Otago, Christchurch.
Assistant Research Fellow, Department of Population Health, University of Otago, Christchurch.
N Z Med J. 2022 May 6;135(1554):93-104.
The availability of legal and illegal drugs is widespread across New Zealand. All drugs have the potential to cause harm to those who use them, and to others. Understanding the nature and extent of these harms depends upon the ongoing and systematic collection of relevant data, which is crucial in achieving the current national policy goal of minimising drug harm. Thus, we aim to describe how information on drug harm is currently collected and measured in New Zealand.
This article maps and evaluates harm data within New Zealand, explores data collection methods and timing, and identifies the substances and types of harm assessed to date. We review large and predominantly administrative datasets that provide a measure of harm, which are collected more than once and/or are updated periodically.
We highlight a number of key gaps and limitations that exist within the current data landscape, and outline barriers to ensuring greater utilisation. We recommend more frequent data collection, including improved data on harms to others, and inclusion of a wider range of drugs.
Implementation of these recommendations will improve the understanding of comprehensive drug harm in New Zealand, to guide effective local harm reduction policies and interventions.
在新西兰,合法和非法药物的供应非常广泛。所有药物都有可能对使用者及其他人造成伤害。了解这些伤害的性质和程度取决于对相关数据的持续系统收集,这对于实现当前将药物伤害最小化的国家政策目标至关重要。因此,我们旨在描述新西兰目前如何收集和衡量药物伤害信息。
本文在新西兰内对伤害数据进行了映射和评估,探讨了数据收集方法和时间,并确定了迄今为止评估的物质和类型的伤害。我们审查了提供伤害衡量标准的大型且主要是行政数据集,这些数据集是多次收集的和/或定期更新的。
我们强调了当前数据格局中存在的一些关键差距和局限性,并概述了确保更大程度利用数据的障碍。我们建议更频繁地收集数据,包括改善对他人伤害的数据,并纳入更广泛的药物。
实施这些建议将提高对新西兰全面药物伤害的理解,以指导有效的当地减少伤害政策和干预措施。